Compare SPOK & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPOK | SLP |
|---|---|---|
| Founded | 2004 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | EDP Services |
| Sector | Telecommunications | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.8M | 248.8M |
| IPO Year | 2004 | 1996 |
| Metric | SPOK | SLP |
|---|---|---|
| Price | $11.78 | $12.44 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $14.00 | ★ $25.00 |
| AVG Volume (30 Days) | 189.9K | ★ 253.8K |
| Earning Date | 01-01-0001 | 04-07-2026 |
| Dividend Yield | ★ 10.43% | N/A |
| EPS Growth | ★ 2.74 | N/A |
| EPS | ★ 0.75 | 0.03 |
| Revenue | ★ $139,708,000.00 | $59,577,000.00 |
| Revenue This Year | $1.70 | $2.64 |
| Revenue Next Year | N/A | $6.01 |
| P/E Ratio | ★ $15.97 | $411.00 |
| Revenue Growth | 1.49 | ★ 10.52 |
| 52 Week Low | $11.68 | $11.16 |
| 52 Week High | $19.31 | $36.43 |
| Indicator | SPOK | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 29.89 | 40.17 |
| Support Level | $11.68 | $12.45 |
| Resistance Level | $13.72 | $13.84 |
| Average True Range (ATR) | 0.43 | 0.51 |
| MACD | -0.09 | 0.29 |
| Stochastic Oscillator | 2.61 | 83.27 |
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.